Cargando…

Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study

BACKGROUND: Rotavirus infection has been proposed as a risk factor for coeliac disease (CD) and type 1 diabetes (T1D). The UK introduced infant rotavirus vaccination in 2013. We have previously shown that rotavirus vaccination can have beneficial off-target effects on syndromes, such as hospitalised...

Descripción completa

Detalles Bibliográficos
Autores principales: Inns, Thomas, Fleming, Kate M., Iturriza-Gomara, Miren, Hungerford, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240289/
https://www.ncbi.nlm.nih.gov/pubmed/34183004
http://dx.doi.org/10.1186/s12916-021-02017-1
_version_ 1783715184038117376
author Inns, Thomas
Fleming, Kate M.
Iturriza-Gomara, Miren
Hungerford, Daniel
author_facet Inns, Thomas
Fleming, Kate M.
Iturriza-Gomara, Miren
Hungerford, Daniel
author_sort Inns, Thomas
collection PubMed
description BACKGROUND: Rotavirus infection has been proposed as a risk factor for coeliac disease (CD) and type 1 diabetes (T1D). The UK introduced infant rotavirus vaccination in 2013. We have previously shown that rotavirus vaccination can have beneficial off-target effects on syndromes, such as hospitalised seizures. We therefore investigated whether rotavirus vaccination prevents CD and T1D in the UK. METHODS: A cohort study of children born between 2010 and 2015 was conducted using primary care records from the Clinical Practice Research Datalink. Children were followed up from 6 months to 7 years old, with censoring for outcome, death or leaving the practice. CD was defined as diagnosis of CD or the prescription of gluten-free goods. T1D was defined as a T1D diagnosis. The exposure was rotavirus vaccination, defined as one or more doses. Mixed-effects Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CIs). Models were adjusted for potential confounders and included random intercepts for general practices. RESULTS: There were 880,629 children in the cohort (48.8% female). A total of 343,113 (39.0%) participants received rotavirus vaccine; among those born after the introduction of rotavirus vaccination, 93.4% were vaccinated. Study participants contributed 4,388,355 person-years, with median follow-up 5.66 person-years. There were 1657 CD cases, an incidence of 38.0 cases per 100,000 person-years. Compared with unvaccinated children, the adjusted HR for a CD was 1.05 (95% CI 0.86–1.28) for vaccinated children. Females had a 40% higher hazard than males. T1D was recorded for 733 participants, an incidence of 17.1 cases per 100,000 person-years. In adjusted analysis, rotavirus vaccination was not associated with risk of T1D (HR = 0.89, 95% CI 0.68–1.19). CONCLUSIONS: Rotavirus vaccination has reduced diarrhoeal disease morbidity and mortality substantial since licencing in 2006. Our finding from this large cohort study did not provide evidence that rotavirus vaccination prevents CD or T1D, nor is it associated with increased risk, delivering further evidence of rotavirus vaccine safety.
format Online
Article
Text
id pubmed-8240289
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82402892021-06-30 Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study Inns, Thomas Fleming, Kate M. Iturriza-Gomara, Miren Hungerford, Daniel BMC Med Research Article BACKGROUND: Rotavirus infection has been proposed as a risk factor for coeliac disease (CD) and type 1 diabetes (T1D). The UK introduced infant rotavirus vaccination in 2013. We have previously shown that rotavirus vaccination can have beneficial off-target effects on syndromes, such as hospitalised seizures. We therefore investigated whether rotavirus vaccination prevents CD and T1D in the UK. METHODS: A cohort study of children born between 2010 and 2015 was conducted using primary care records from the Clinical Practice Research Datalink. Children were followed up from 6 months to 7 years old, with censoring for outcome, death or leaving the practice. CD was defined as diagnosis of CD or the prescription of gluten-free goods. T1D was defined as a T1D diagnosis. The exposure was rotavirus vaccination, defined as one or more doses. Mixed-effects Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CIs). Models were adjusted for potential confounders and included random intercepts for general practices. RESULTS: There were 880,629 children in the cohort (48.8% female). A total of 343,113 (39.0%) participants received rotavirus vaccine; among those born after the introduction of rotavirus vaccination, 93.4% were vaccinated. Study participants contributed 4,388,355 person-years, with median follow-up 5.66 person-years. There were 1657 CD cases, an incidence of 38.0 cases per 100,000 person-years. Compared with unvaccinated children, the adjusted HR for a CD was 1.05 (95% CI 0.86–1.28) for vaccinated children. Females had a 40% higher hazard than males. T1D was recorded for 733 participants, an incidence of 17.1 cases per 100,000 person-years. In adjusted analysis, rotavirus vaccination was not associated with risk of T1D (HR = 0.89, 95% CI 0.68–1.19). CONCLUSIONS: Rotavirus vaccination has reduced diarrhoeal disease morbidity and mortality substantial since licencing in 2006. Our finding from this large cohort study did not provide evidence that rotavirus vaccination prevents CD or T1D, nor is it associated with increased risk, delivering further evidence of rotavirus vaccine safety. BioMed Central 2021-06-29 /pmc/articles/PMC8240289/ /pubmed/34183004 http://dx.doi.org/10.1186/s12916-021-02017-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Inns, Thomas
Fleming, Kate M.
Iturriza-Gomara, Miren
Hungerford, Daniel
Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study
title Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study
title_full Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study
title_fullStr Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study
title_full_unstemmed Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study
title_short Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study
title_sort paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240289/
https://www.ncbi.nlm.nih.gov/pubmed/34183004
http://dx.doi.org/10.1186/s12916-021-02017-1
work_keys_str_mv AT innsthomas paediatricrotavirusvaccinationcoeliacdiseaseandtype1diabetesinchildrenapopulationbasedcohortstudy
AT flemingkatem paediatricrotavirusvaccinationcoeliacdiseaseandtype1diabetesinchildrenapopulationbasedcohortstudy
AT iturrizagomaramiren paediatricrotavirusvaccinationcoeliacdiseaseandtype1diabetesinchildrenapopulationbasedcohortstudy
AT hungerforddaniel paediatricrotavirusvaccinationcoeliacdiseaseandtype1diabetesinchildrenapopulationbasedcohortstudy